RSNA 2014 

Abstract Archives of the RSNA, 2014


CAE165

The Transition to Quantitative Cardiac Imaging: Navigating Quantitative Maps— Where Do We Stand and Where Do We Go from Here?

Education Exhibits

Presented in 2014

Participants

Jad Marwan Bou Ayache MD, Presenter: Nothing to Disclose
Marcos Paulo Ferreira Botelho MD, Abstract Co-Author: Nothing to Disclose
James Christopher Carr MD, Abstract Co-Author: Research Grant, Astellas Group Research support, Siemens AG Speaker, Siemens AG Advisory Board, Guerbet SA
Benjamin Freed, Abstract Co-Author: Nothing to Disclose
Oisin Jude Flanagan MBBCh, MRCPI, Abstract Co-Author: Nothing to Disclose
Daniel Lee, Abstract Co-Author: Research funded, CardiacAssist, Inc Spouse, Employee, Takeda Pharmaceutical Company Limited
Jeremy Douglas Collins MD, Abstract Co-Author: Consultant, B. Braun Melsungen AG

TEACHING POINTS

1. Review the techniques for in vivo myocardial T1 and T2 quantitative imaging. 2. Summarize literature supporting the clinical utility of quantitative myocardial T1 and T2 imaging. 3. Review of clinical cases illustrating the clinical benefit of integrating quantitative T1 and T2 imaging into cardiac MRI protocols.

TABLE OF CONTENTS/OUTLINE

1. The need for quantitative imaging to supplement qualitative MRI examination. 2. T1 parametric mapping a) History and Background, highlighting the pitfalls of quantitative approaches on conventional delayed enhancement imaging sequences. b) Physical principles c) Review different pulse sequences for quantitative T1 imaging. d) Summarize the literature supporting the clinical utility of quantitative T1 imaging at cardiac MRI. 3. T2 parametric mapping a) History and Background, highlighting the pitfalls of qualitative interpretation of T2 weighted dark blood imaging. b) Physical principles c) Review different approache for quantitative T2 imaging. d) Summarize the literature supporting the clinical utility of quantitative T2 imaging at cardiac MRI. 4. Case examples a) T2 quantitative imaging: myocarditis, vasculitis, infarction, takotsubo cardiomyopathy, and heart transplant rejection. b) T1 quantitative imaging : amyloidosis, scleroderma, endomyocardial fibroelastosis, thrombus, and HCM.

PDF UPLOAD

http://abstract.rsna.org/uploads/2014/14012461/14012461_tgm5.pdf

Cite This Abstract

Bou Ayache, J, Botelho, M, Carr, J, Freed, B, Flanagan, O, Lee, D, Collins, J, The Transition to Quantitative Cardiac Imaging: Navigating Quantitative Maps— Where Do We Stand and Where Do We Go from Here?.  Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL. http://archive.rsna.org/2014/14012461.html